AxoGen Investor Relations Material
Latest events
Q2 2025
AxoGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AxoGen Inc
Access all reports
AxoGen Inc develops and markets surgical solutions for peripheral nerve injuries. The company provides nerve grafts, connectors, and related products used by surgeons to repair damaged or severed nerves. It serves hospitals and surgical centers across the United States. The company is headquartered in Alachua, Florida, and its shares are listed on the NASDAQ.
Key slides for AxoGen Inc
Q2 2025
AxoGen Inc
Investor Day 2025
AxoGen Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AXGN
Country
🇺🇸 United States